Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04632225
What this trial is testing

Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Helixmith Co., Ltd. 18
Not applicableStudy completedNCT02582385
What this trial is testing

In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Brugmann University Hospital 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04220021
What this trial is testing

Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Who this might be right for
C9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia
University of Florida 41
Not applicableStudy completedNCT02011204
What this trial is testing

Study of Electrical Impedance Myography (EIM) in ALS

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseCharcot-Marie-Tooth Disease+1 more
Skulpt, Inc. 106
Early research (Phase 1)UnknownNCT00673140
What this trial is testing

Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
GAAD Medical Research Institute Inc. 7
Testing effectiveness (Phase 2)Ended earlyNCT06441682
What this trial is testing

A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
argenx 60
Early research (Phase 1)Active Not RecruitingNCT05279755
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
ProJenX 72
Testing effectiveness (Phase 2)Study completedNCT03114215
What this trial is testing

Effect of MD1003 in Amyotrophic Lateral Sclerosis

Who this might be right for
ALSAmyotrophic Lateral SclerosisMotor Neuron Disease
MedDay Pharmaceuticals SA 30
Early research (Phase 1)Active Not RecruitingNCT07618585
What this trial is testing

Safety and Efficacy of Intrathecal NTF001 Injection in ALS

Who this might be right for
ALS - Amyotrophic Lateral SclerosisALS (Amyotrophic Lateral Sclerosis)
Ruijin Hospital 12
Large-scale testing (Phase 3)Study completedNCT04436497
What this trial is testing

HEALEY ALS Platform Trial - Regimen A Zilucoplan

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 162
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Testing effectiveness (Phase 2)Ended earlyNCT03580616
What this trial is testing

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Elijah W. Stommel 43
Testing effectiveness (Phase 2)Study completedNCT01232738
What this trial is testing

Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Yunxia Wang, MD 36
Large-scale testing (Phase 3)Ended earlyNCT00839033
What this trial is testing

Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders

Who this might be right for
Duchenne Muscular DystrophyAmyotrophic Lateral SclerosisNeuromuscular Diseases
Assistance Publique - Hôpitaux de Paris 14
Not applicableUnknownNCT03806647
What this trial is testing

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1)

Who this might be right for
Amyotrophic Lateral Sclerosis
Taipei Veterans General Hospital, Taiwan 20
Testing effectiveness (Phase 2)Study completedNCT00244244
What this trial is testing

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
CytRx 80
Testing effectiveness (Phase 2)Study completedNCT02450552
What this trial is testing

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

Who this might be right for
Amyotrophic Lateral Sclerosis
Brian Wainger 65
Early research (Phase 1)Study completedNCT01424163
What this trial is testing

Dexpramipexole Japanese PK Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 57
Testing effectiveness (Phase 2)Ended earlyNCT06903286
What this trial is testing

Extension Study of Participants From SPG302-ALS-001

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Spinogenix 16
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Next Page